Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John-Michael Gamble

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Diabetes Research and Clinical Practice|December 21, 2017
The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort studyJohn-Michael Gamble, Jennifer R Donnan, Eugene Chibrikov, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|June 9, 2021
Variation and appropriateness of antipsychotic use in long-term care facilities across Newfoundland and LabradorZachary E M Giovannini-Green, John-Michael Gamble, Brendan Barrett, et al.
Scientific Reports|October 13, 2018
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute OutcomesJohn-Michael Gamble, Jennifer R Donnan, Eugene Chibrikov, et al.
Diabetes Care|December 14, 2022
Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort StudyWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Diabetes Care|June 14, 2023
Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort StudyWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Hospital Pharmacy|May 12, 2025
Unpacking Oral Challenge Protocols: A Descriptive Epidemiologic Study of Reactions, Predictors, and Practices for Delabeling Low-Risk Penicillin Allergies Leveraging Data from a Systematic Review and Meta-AnalysisMira Maximos, Ryan Pelletier, Sameer Elsayed, et al.
Respiratory Medicine|December 21, 2011
Guideline adherence and macrolides reduced mortality in outpatients with pneumoniaLeyla Asadi, Dean T Eurich, John-Michael Gamble, et al.
British Journal of Clinical Pharmacology|December 20, 2024
A systematic review and meta-analysis of interventions to delabel low-risk penicillin allergies with consideration for sex and genderMira Maximos, Ryan Pelletier, Sameer Elsayed, et al.
Medical Care|December 7, 2013
Changes in thiazolidinedione use and outcomes following removal of a prior-authorization policy: controlled time-series analysisJohn-Michael Gamble, Sumit R Majumdar, Jeffrey A Johnson, et al.
Pharmacoepidemiology and Drug Safety|March 12, 2013
Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure dataJohn-Michael Gamble, Jeffrey A Johnson, Sumit R Majumdar, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Diabetes Research and Clinical Practice|December 21, 2017
The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort studyJohn-Michael Gamble, Jennifer R Donnan, Eugene Chibrikov, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|June 9, 2021
Variation and appropriateness of antipsychotic use in long-term care facilities across Newfoundland and LabradorZachary E M Giovannini-Green, John-Michael Gamble, Brendan Barrett, et al.
Scientific Reports|October 13, 2018
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute OutcomesJohn-Michael Gamble, Jennifer R Donnan, Eugene Chibrikov, et al.
Diabetes Care|December 14, 2022
Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort StudyWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Diabetes Care|June 14, 2023
Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort StudyWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Hospital Pharmacy|May 12, 2025
Unpacking Oral Challenge Protocols: A Descriptive Epidemiologic Study of Reactions, Predictors, and Practices for Delabeling Low-Risk Penicillin Allergies Leveraging Data from a Systematic Review and Meta-AnalysisMira Maximos, Ryan Pelletier, Sameer Elsayed, et al.
Respiratory Medicine|December 21, 2011
Guideline adherence and macrolides reduced mortality in outpatients with pneumoniaLeyla Asadi, Dean T Eurich, John-Michael Gamble, et al.
British Journal of Clinical Pharmacology|December 20, 2024
A systematic review and meta-analysis of interventions to delabel low-risk penicillin allergies with consideration for sex and genderMira Maximos, Ryan Pelletier, Sameer Elsayed, et al.
Medical Care|December 7, 2013
Changes in thiazolidinedione use and outcomes following removal of a prior-authorization policy: controlled time-series analysisJohn-Michael Gamble, Sumit R Majumdar, Jeffrey A Johnson, et al.
Pharmacoepidemiology and Drug Safety|March 12, 2013
Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure dataJohn-Michael Gamble, Jeffrey A Johnson, Sumit R Majumdar, et al.
Pageof 8